Prior to his involvement with Barron Venture Partners, Mr. Worden founded LifeSpan Vision Ventures in 2022, Since then, the venture capital fund has made over twenty investments primarily in therapeutics with a focus on longevity and lifespan.

Mr. Worden founded GameChange Solar in 2012 with the vision to make solar energy become the lowest cost technology for electricity generation globally. In order to do this, Mr. Worden grew GameChange Solar by improving technology and leveraging massive scale manufacturing to aggressively cost reduce its systems and substantially reduce the total cost of solar power plants.

GameChange Solar has grown from a startup in 2012 to become a global leader with over $1 billion in profitable sales in 2022. Solar energy is now among the lowest cost for electricity generation in most world markets.

In 2010, Prior to GameChange Solar, Mr. Worden founded Soltas Energy to develop and own solar power plants. This company built ten solar power plants, which were then successfully sold by 2014.

Prior to 2010, Mr. Worden has decades of experience as an investor primarily with Barron Partners LP, which was a global long-only investment partnership. While managing Barron Partners LP, Mr. Worden oversaw investments in over 170 companies globally in multiple industries. Many of these companies were either public or private companies which later became public. The investments in each company ranged up to $15 million each.

Mr. Worden was the General Partner of Barron and ultimately the largest investor as well. Mr. Worden changed his primary focus from investments to renewable energy starting with Soltas Energy and then with GameChange Solar.

In addition, Mr. Worden is the founder and serves as a director of the Barron Charitable Foundation, a non-profit organization dedicated to helping those in need.

He has also established and funded Harvard University’s John A. Paulson School of Engineering and Applied Sciences, The Andrew Barron Worden SEAS Dean’s Innovation Fund, which is dedicated to funding scientific research in the areas of cleantech, AI, medical, and others.